ASPR to test automated sterile saline system to help prevent IV shortages
The Department of Health and Human Services’ Administration for Strategic Preparedness and Response June 5 announced it selected two locations to test an automated, point-of-care, sterile saline manufacturing system that could help prevent or mitigate intravenous fluid shortages in the U.S. The system, called Caspian, began development in 2019. One unit will be tested at Walter Reed Medical Center in Bethesda, Md., while the other will be tested and reviewed by the Food and Drug Administration. ASPR has been working with Manchester, N.H.-based DEKA Research and Development Corp. on manufacturing the units, with the intent of producing up to 500 bags of IV fluid per day.
Related News Articles
Headline
The U.S. Trade Representative yesterday announced it is implementing a 10% or 12.5% tariff on 60 trading partners, which became effective today. These…
Headline
The Food and Drug Administration July 10 released a proposed rule that would modernize drug establishment registration requirements, with implications for…
Headline
The AHA today sent a letter to the Office of the United States Trade Representative to ask that medications, medical devices and other healthcare…
Headline
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…
Headline
The Administration for Strategic Preparedness and Response June 16 announced the launch of the Digital Stockpile and Manufacturing Response Network Challenge,…
Headline
The U.S. Trade Representative yesterday announced plans to impose additional tariffs on goods from certain nations that it said had lacked or failed…